Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.250
-0.130 (-3.85%)
At close: Mar 10, 2026, 4:00 PM EDT
3.330
+0.080 (2.46%)
After-hours: Mar 10, 2026, 6:28 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $73.66 million as of March 10, 2026. Its market cap has increased by 16.65% in one year.
Market Cap
73.66M
Enterprise Value
71.14M
1-Year Change
16.65%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $73.66M, an increase of 16.72%. That is a compound annual growth rate of 2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 76.60M | -44.41% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 475.96M |
| Fulgent Genetics | 447.22M |
| Prenetics Global | 338.59M |
| Burning Rock Biotech | 244.19M |
| Biodesix | 182.03M |
| Insight Molecular Diagnostics | 174.34M |
| MDxHealth | 172.58M |
| FONAR | 121.15M |